What's Happening?
Velocity Clinical Research has announced the appointment of Dr. Ronnie Beboso as the UK Medical Director. Dr. Beboso brings 20 years of experience in clinical research, having worked on over 70 studies across various therapeutic areas. In his new role, he will oversee UK physicians, provide strategic medical leadership, and support the evolution of Velocity's medical model to meet the needs of a growing pan-European organization. Dr. Beboso has held senior research physician roles at IQVIA and Chiltern, and most recently served as a Senior Clinical Research Physician at Accellacare Clinical Research. His appointment is part of Velocity's commitment to maintaining strong medical leadership as it scales its clinical operations across Europe.
Why It's Important?
The
appointment of Dr. Beboso is significant as it underscores Velocity Clinical Research's focus on expanding its European presence while ensuring high-quality medical leadership. This move is expected to enhance the company's ability to conduct clinical trials efficiently across Europe, benefiting pharmaceutical and biotechnology companies seeking to develop new drugs and medical devices. Dr. Beboso's extensive experience in clinical research and his ability to mentor physicians will be crucial in maintaining clinical excellence and supporting physician career progression. This strategic appointment aligns with Velocity's goal of balancing scale with quality in its clinical research model.
What's Next?
Dr. Beboso will continue to act as Principal Investigator on selected studies while focusing on mentoring and developing the next generation of investigators across the UK. He will support physician career progression and expand therapeutic capabilities, ensuring clinical excellence remains central as Velocity grows. Velocity operates 17 integrated sites across Europe and has over 70 locations globally, providing access to more than 220 principal investigators and 1.5 million patients. The company aims to leverage its centralized infrastructure and technology backbone to deliver high-quality data and superior patient enrollment.
